Interim Report from Project ImPACT: Hyperlipidemia
- 1 September 1998
- journal article
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 38 (5) , 529-534
- https://doi.org/10.1016/s1086-5802(16)30377-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Persistence of Use of Lipid-Lowering MedicationsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Physician extenders for cost-effective management of hypercholesterolemiaJournal of General Internal Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?New England Journal of Medicine, 1995
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Effect of Clinical Pharmacy Services on Patients with Essential HypertensionCirculation, 1973